Devlina Roy1, Ritwik Ghosh1, Souvik Dubey2, Mahua Jana Dubey3, Julián Benito-León4,5,6, Biman Kanti Ray2. 1. Department of General Medicine, Burdwan Medical College, Burdwan, West Bengal, India. 2. Department of Neuromedicine, Bangur Institute of Neurosciences (BIN), Kolkata, West Bengal, India. 3. Department of Psychiatry, Berhampore Mental Hospital, Behrampore, West Bengal, India. 4. Department of Neurology, University Hospital, "12 de Octubre", Madrid, Spain. 5. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. 6. Department of Medicine, Universidad Complutense, Madrid, Spain.
Abstract
BACKGROUND: Albeit primarily a disease of respiratory tract, the 2019 coronavirus infectious disease (COVID-19) has been found to have causal association with a plethora of neurological, neuropsychiatric and psychological effects. This review aims to analyze them with a discussion of evolving therapeutic recommendations. METHODS: PubMed and Google Scholar were searched from 1 January 2020 to 30 May 2020 with the following key terms: "COVID-19", "SARS-CoV-2", "pandemic", "neuro-COVID", "stroke-COVID", "epilepsy-COVID", "COVID-encephalopathy", "SARS-CoV-2-encephalitis", "SARS-CoV-2-rhabdomyolysis", "COVID-demyelinating disease", "neurological manifestations", "psychosocial manifestations", "treatment recommendations", "COVID-19 and therapeutic changes", "psychiatry", "marginalised", "telemedicine", "mental health", "quarantine", "infodemic" and "social media". A few newspaper reports related to COVID-19 and psychosocial impacts have also been added as per context. RESULTS: Neurological and neuropsychiatric manifestations of COVID-19 are abundant. Clinical features of both central and peripheral nervous system involvement are evident. These have been categorically analyzed briefly with literature support. Most of the psychological effects are secondary to pandemic-associated regulatory, socioeconomic and psychosocial changes. CONCLUSION: Neurological and neuropsychiatric manifestations of this disease are only beginning to unravel. This demands a wide index of suspicion for prompt diagnosis of SARS-CoV-2 to prevent further complications and mortality.
BACKGROUND: Albeit primarily a disease of respiratory tract, the 2019 coronavirus infectious disease (COVID-19) has been found to have causal association with a plethora of neurological, neuropsychiatric and psychological effects. This review aims to analyze them with a discussion of evolving therapeutic recommendations. METHODS: PubMed and Google Scholar were searched from 1 January 2020 to 30 May 2020 with the following key terms: "COVID-19", "SARS-CoV-2", "pandemic", "neuro-COVID", "stroke-COVID", "epilepsy-COVID", "COVID-encephalopathy", "SARS-CoV-2-encephalitis", "SARS-CoV-2-rhabdomyolysis", "COVID-demyelinating disease", "neurological manifestations", "psychosocial manifestations", "treatment recommendations", "COVID-19 and therapeutic changes", "psychiatry", "marginalised", "telemedicine", "mental health", "quarantine", "infodemic" and "social media". A few newspaper reports related to COVID-19 and psychosocial impacts have also been added as per context. RESULTS: Neurological and neuropsychiatric manifestations of COVID-19 are abundant. Clinical features of both central and peripheral nervous system involvement are evident. These have been categorically analyzed briefly with literature support. Most of the psychological effects are secondary to pandemic-associated regulatory, socioeconomic and psychosocial changes. CONCLUSION: Neurological and neuropsychiatric manifestations of this disease are only beginning to unravel. This demands a wide index of suspicion for prompt diagnosis of SARS-CoV-2 to prevent further complications and mortality.
Authors: Seungyon Koh; Yoon Seob Kim; Min Hye Kim; Young Hwa Choi; Jun Young Choi; Tae-Joon Kim Journal: BMC Neurol Date: 2022-07-11 Impact factor: 2.903
Authors: Adrian I Espiritu; Marie Charmaine C Sy; Veeda Michelle M Anlacan; Roland Dominic G Jamora Journal: J Neural Transm (Vienna) Date: 2021-08-27 Impact factor: 3.575
Authors: Nuvia Mackenzie; Eva Lopez-Coronel; Alberto Dau; Dieb Maloof; Salvador Mattar; Jesus Tapia Garcia; Briyis Fontecha; Cristina M Lanata; Hernan Felipe Guillen-Burgos Journal: BMC Neurol Date: 2021-03-23 Impact factor: 2.474